InvestorsHub Logo
Followers 16
Posts 1062
Boards Moderated 0
Alias Born 09/01/2019

Re: Vanilla Fitbit post# 39769

Thursday, 05/27/2021 12:58:38 PM

Thursday, May 27, 2021 12:58:38 PM

Post# of 44690
Pending litigation will FU both NRXP and RLF, no doubt. A COORDINATED EFFORT to move Aviptadil forward would have been NICE and we COULD have had steady PPS increases. Apparently 'compensation committee' work and raising money for a wider PIPEline took precedence.
They Didn't even Mention the ongoing CTs in the PR.
https://clinicaltrials.gov/ct2/show/NCT04536350?term=aviptadil&draw=2&rank=2

https://clinicaltrials.gov/ct2/show/NCT04844580?term=aviptadil&draw=2&rank=3

NRX is running a couple CTs and RLF has two Inhaler Trials too, Swiss and Turkey. Coordination/cooperation? Apparently NOT. The squabble has also affected NRXp with a declining PPS and dribble volume. Out of nrxp 5-23 and out of here after this BS.
GEM MUST BEEE SOOOO Happpppyyyy. (NOT) I expect liquidity will surely happen and TM's target may occur here.

Completion dates for RLF Inhaler CTs are EOY, leaving plenty of time for Litigations. OMG. Obviously, MY Long hopes for Cooperation or merging for mutual benefit is dimming Fast. Blacked Out?
Even RUMOR of Courts will kill both companies and trash Aviptadil. More DELAYS, WTF.
I was willing to chance a RS for COOPERATIVE EFFORTS, NOT NOW.
Just My Last Humble Fkn Opinions?...GLTA